Other putative growth factor receptors that could be targeted against pancreatic cancer using CARs include insulin-like growth factor receptor-1 (IGF1R), EGFR, vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR) and platelet-derived growth factors (PDGFRs) that are expressed at elevated levels in pancreatic cancers and contribute the cancer's malignant phenotype (55). The gene discussed is EGFR; the disease is pancreatic neoplasm.